Evidence map›Paper›PMID 26609009›Full record

ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2016

Can ovarian suppression with gonadotropin-releasing hormone analogs (GnRHa) preserve fertility in cancer patients?

K Rodriguez-Wallberg, V Turan, P Munster, K Oktay

Open access · greenAbstract readLetter
In one paragraph

Article in Annals of oncology : official journal of the European Society for Medical Oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Fertility preservation in ovarian tumours.Ecancermedicalscience · 2018
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

K Rodriguez-WallbergDepartment of Oncology-Pathology, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.
V TuranDepartment of Obstetrics and Gynecology, New York Medical College, Valhalla Innovation Institute for Fertility Preservation and IVF, New York.
P MunsterHelen Diller Cancer Center, University of California, San Francisco.
K OktayInnovation Institute for Fertility Preservation and IVF, New York Laboratory of Molecular Reproduction and Fertility Preservation, Division of Reproductive Medicine, Department of Obstetrics and Gynecology, New York Medical College, Valhalla, USA koktay@fertilitypreservation.org.
New York Medical College · USKarolinska University Hospital · SEUniversity of California, San Francisco · US

Funding

Characterization & Prevention of Chemotherapy-Induced Damage to Ovarian ReserveR01HD053112 · NICHD · YALE UNIVERSITY · PI KUTLUK H OKTAY · 2007 to 2026
$7.6M
NICHD NIH HHS R01 HD053112
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AmenorrheaAntineoplastic AgentsBreast NeoplasmsDisease-Free SurvivalFemaleFertilityFertility PreservationGonadotropin-Releasing HormoneHumansOvarian ReserveOvaryPrimary Ovarian InsufficiencyAntineoplastic AgentsGonadotropin-Releasing Hormone

Identifiers

PMID26609009
PMCPMC6267935
OpenAlexW2212245667

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.